Marshall Posner, MD, Medical Director, Head and Neck Oncology Center, Mount Sinai Medical Center, discusses factors that contribute to an improved prognosis for patients with HPV-positive head and neck cancer when compared to patients who are HPV-negative.
Posner explains that several retrospective studies have confirmed that HPV-positive oropharyngeal cancer is highly response to surgery, radiotherapy, and chemotherapy. This translates into a better prognosis for patients with HPV-positive disease.
This is via OncLive an American cancer community and news outlet. Click here to visit the full article.